Astroglial FMRP deficiency cell-autonomously up-regulates miR-128 and disrupts developmental astroglial mGluR5 signaling.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
06 10 2020
Historique:
pubmed: 23 9 2020
medline: 25 11 2020
entrez: 22 9 2020
Statut: ppublish

Résumé

The loss of fragile X mental retardation protein (FMRP) causes fragile X syndrome (FXS), the most common inherited intellectual disability. How the loss of FMRP alters protein expression and astroglial functions remains essentially unknown. Here we showed that selective loss of astroglial FMRP in vivo up-regulates a brain-enriched miRNA, miR-128-3p, in mouse and human FMRP-deficient astroglia, which suppresses developmental expression of astroglial metabotropic glutamate receptor 5 (mGluR5), a major receptor in mediating developmental astroglia to neuron communication. Selective in vivo inhibition of miR-128-3p in FMRP-deficient astroglia sufficiently rescues decreased mGluR5 function, while astroglial overexpression of miR-128-3p strongly and selectively diminishes developmental astroglial mGluR5 signaling. Subsequent transcriptome and proteome profiling further suggests that FMRP commonly and preferentially regulates protein expression through posttranscriptional, but not transcriptional, mechanisms in astroglia. Overall, our study defines an FMRP-dependent cell-autonomous miR pathway that selectively alters developmental astroglial mGluR5 signaling, unveiling astroglial molecular mechanisms involved in FXS pathogenesis.

Identifiants

pubmed: 32958647
pii: 2014080117
doi: 10.1073/pnas.2014080117
pmc: PMC7547241
doi:

Substances chimiques

FMR1 protein, human 0
Grm5 protein, mouse 0
MIRN128 microRNA, human 0
MicroRNAs 0
Receptor, Metabotropic Glutamate 5 0
Fragile X Mental Retardation Protein 139135-51-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

25092-25103

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS105200
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH106490
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH118827
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH116582
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD090256
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS105339
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA025128
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH113780
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50
pubmed: 12032354
Science. 2013 Dec 6;342(6163):1254-8
pubmed: 24311694
Neuron. 2008 Oct 23;60(2):201-14
pubmed: 18957214
Nat Neurosci. 2011 Aug 14;14(9):1115-7
pubmed: 21841775
Neuron. 2016 Jan 6;89(1):37-53
pubmed: 26687838
Neuron. 2010 Feb 11;65(3):373-84
pubmed: 20159450
Trends Mol Med. 2007 Feb;13(2):54-63
pubmed: 17207662
Nat Rev Neurosci. 2007 Dec;8(12):935-47
pubmed: 17987031
Glia. 2007 Nov 15;55(15):1601-9
pubmed: 17823967
Neuroscience. 2006;138(2):501-10
pubmed: 16414198
J Neurosci. 2010 Mar 24;30(12):4508-14
pubmed: 20335488
Nat Biotechnol. 2009 Mar;27(3):275-80
pubmed: 19252484
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11397-E11405
pubmed: 30373821
Nat Protoc. 2014;9(6):1282-91
pubmed: 24810037
Front Mol Neurosci. 2017 Oct 20;10:340
pubmed: 29104533
Hum Mol Genet. 2013 May 15;22(10):2041-54
pubmed: 23396537
Elife. 2016 Feb 17;5:
pubmed: 26883496
Cell. 2017 Sep 7;170(6):1209-1223.e20
pubmed: 28823556
J Neurosci. 2010 Jan 13;30(2):694-702
pubmed: 20071534
RNA. 2009 Mar;15(3):362-6
pubmed: 19155329
Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1995-2000
pubmed: 17259307
Neurobiol Dis. 2006 Mar;21(3):549-55
pubmed: 16257225
J Biomed Biotechnol. 2006;2006(4):64347
pubmed: 17057366
Nat Neurosci. 2004 Feb;7(2):113-7
pubmed: 14703574
Cell. 2008 Nov 14;135(4):749-62
pubmed: 19013282
Front Mol Neurosci. 2019 Mar 07;12:51
pubmed: 30899214
Neuron. 2017 Aug 2;95(3):550-563.e5
pubmed: 28772121
Neuron. 2015 Aug 19;87(4):699-715
pubmed: 26291156
Glia. 2020 Sep 24;:
pubmed: 32970902
Cell Rep. 2015 May 5;11(5):727-36
pubmed: 25921541
Nat Biotechnol. 2011 May 22;29(6):528-34
pubmed: 21602806
J Neurosci. 1995 Sep;15(9):6103-9
pubmed: 7666194
Nat Biotechnol. 2016 Feb;34(2):204-9
pubmed: 26829320
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14374-8
pubmed: 14614133
Curr Biol. 2014 Aug 4;24(15):1679-88
pubmed: 25042585
Methods Mol Biol. 2008;433:287-299
pubmed: 18679631
J Neurosci. 2017 Sep 6;37(36):8706-8717
pubmed: 28821665
Cell Rep. 2018 Oct 23;25(4):947-958.e4
pubmed: 30355500
Int J Physiol Pathophysiol Pharmacol. 2012;4(3):140-8
pubmed: 23071871
Genome Res. 2016 Oct;26(10):1411-1416
pubmed: 27516621
Neuron. 2010 Feb 11;65(3):385-98
pubmed: 20159451
Nat Neurosci. 2016 Feb;19(2):182-9
pubmed: 26814587
Glia. 2011 Feb;59(2):200-7
pubmed: 21046559
J Gen Physiol. 2013 May;141(5):633-47
pubmed: 23589582
Cell. 2011 Jul 22;146(2):247-61
pubmed: 21784246
Science. 2013 Jan 11;339(6116):197-200
pubmed: 23307741
Cell. 1991 May 31;65(5):905-14
pubmed: 1710175
Neuron. 2017 Nov 1;96(3):697-708
pubmed: 29096081
J Neurosci. 2014 Aug 13;34(33):10950-62
pubmed: 25122895
Neuron. 2014 Jun 18;82(6):1263-70
pubmed: 24945771
J Neurosci. 2016 Jul 6;36(27):7079-94
pubmed: 27383586
RNA. 2008 Sep;14(9):1834-44
pubmed: 18697922

Auteurs

Yuqin Men (Y)

Department of Neuroscience, Tufts University, Boston, MA 02111.

Liang Ye (L)

Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229.
Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229.

Ryan D Risgaard (RD)

Waisman Center, University of Wisconsin-Madison, Madison, WI 53705.
Department of Neuroscience, University of Wisconsin-Madison, Madison, WI 53705.

Vanessa Promes (V)

Department of Neuroscience, Tufts University, Boston, MA 02111.

Xinyu Zhao (X)

Waisman Center, University of Wisconsin-Madison, Madison, WI 53705.
Department of Neuroscience, University of Wisconsin-Madison, Madison, WI 53705.

Martin Paukert (M)

Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229.
Center for Biomedical Neuroscience, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229.

Yongjie Yang (Y)

Department of Neuroscience, Tufts University, Boston, MA 02111; yongjie.yang@tufts.edu.
Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH